ACM
BIO icon

Atlanta Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-241,517
Closed -$141M 171
2020
Q4
$141M Sell
241,517
-156,456
-39% -$91.2M 0.5% 73
2020
Q3
$205M Sell
397,973
-53,606
-12% -$27.6M 0.84% 49
2020
Q2
$204M Sell
451,579
-3,769
-0.8% -$1.7M 0.86% 46
2020
Q1
$160M Sell
455,348
-294,481
-39% -$103M 0.83% 50
2019
Q4
$277M Sell
749,829
-3,463
-0.5% -$1.28M 1.15% 28
2019
Q3
$251M Sell
753,292
-2,343
-0.3% -$780K 1.09% 31
2019
Q2
$236M Buy
755,635
+5,522
+0.7% +$1.73M 1.06% 32
2019
Q1
$229M Buy
750,113
+1,093
+0.1% +$334K 1.1% 31
2018
Q4
$174M Sell
749,020
-569,115
-43% -$132M 0.96% 38
2018
Q3
$413M Sell
1,318,135
-144,418
-10% -$45.2M 1.92% 14
2018
Q2
$422M Sell
1,462,553
-7,194
-0.5% -$2.08M 2.12% 10
2018
Q1
$368M Sell
1,469,747
-5,128
-0.3% -$1.28M 1.9% 13
2017
Q4
$352M Sell
1,474,875
-100,847
-6% -$24.1M 1.85% 15
2017
Q3
$350M Sell
1,575,722
-71,478
-4% -$15.9M 1.98% 13
2017
Q2
$373M Sell
1,647,200
-107,401
-6% -$24.3M 2.18% 6
2017
Q1
$350M Sell
1,754,601
-30,292
-2% -$6.04M 2.15% 7
2016
Q4
$325M Sell
1,784,893
-8,903
-0.5% -$1.62M 2.07% 7
2016
Q3
$294M Buy
1,793,796
+24,677
+1% +$4.04M 1.95% 10
2016
Q2
$253M Buy
1,769,119
+42,593
+2% +$6.09M 1.69% 15
2016
Q1
$236M Sell
1,726,526
-11,960
-0.7% -$1.64M 1.68% 18
2015
Q4
$241M Sell
1,738,486
-1,658
-0.1% -$230K 1.77% 12
2015
Q3
$234M Buy
1,740,144
+1,783
+0.1% +$239K 1.76% 10
2015
Q2
$262M Sell
1,738,361
-49,763
-3% -$7.49M 1.78% 8
2015
Q1
$242M Sell
1,788,124
-16,053
-0.9% -$2.17M 1.64% 7
2014
Q4
$218M Sell
1,804,177
-22,470
-1% -$2.71M 1.49% 11
2014
Q3
$207M Sell
1,826,647
-11,307
-0.6% -$1.28M 1.49% 13
2014
Q2
$220M Buy
1,837,954
+37,626
+2% +$4.5M 1.5% 13
2014
Q1
$231M Sell
1,800,328
-9,660
-0.5% -$1.24M 1.59% 10
2013
Q4
$224M Buy
1,809,988
+96,656
+6% +$11.9M 1.47% 14
2013
Q3
$201M Buy
1,713,332
+5,337
+0.3% +$627K 1.43% 12
2013
Q2
$192M Buy
+1,707,995
New +$192M 1.45% 13